China Compulsory Licensing Reg Opens Door For Generics Of Patented Drugs
This article was originally published in PharmAsia News
Executive Summary
Taking the lead from India’s recent compulsory license for Bayer’s Nexavar, China passes a compulsory license regulation that could allow generics on patented drugs.